Reproductive Health Medicines

Quality Assurance Policy for RH Medicines

Publication Date: November 2012
Author: UNFPA


UNFPA procures medicines that have been selected from the WHO Model List of Essential Medicines as well as National Essential Drugs Lists. In consultation with WHO and other UN agencies, UNFPA has developed a Quality Assurance Policy for Reproductive Health Medicines. The suppliers of medicines procured by UNFPA must have a current Good Manufacturing Practice certification issued by an authority part of the Pharmaceutical Inspection Co-operation Scheme, PIC/s, manufacturing licenses, national regulatory approval, and be qualified for procurement through the evaluation processes outlined in the Policy.

Related content

This form should be completed to request an order through UNFPA.
UNFPA Procurement Services Branch invites qualified suppliers to submit a bid for the supply of dignity kits.
The Procurement Services Branch (PSB) performs an annual analysis of UNFPA Pharmaceuticals and In-vitro Diagnostics Spend.


We use cookies and other identifiers to help improve your online experience. By using our website you agree to this. To learn more, including how to change your settings, see our cookies policy.